Author:
Wybranowski Tomasz,Ziomkowska Blanka,Cyrankiewicz Michał,Bosek Maciej,Pyskir Jerzy,Napiórkowska Marta,Kruszewski Stefan
Abstract
AbstractThe aim of this study was to examine the usefulness of time-resolved fluorescence spectroscopy in the evaluation of the oxidative processes in human plasma. To investigate the impact of oxidative stress on the fluorescence of plasma, five studied markers (thiobarbituric acid-reactive substances, ischemia modified albumin, carbonyl groups, hydrogen peroxide, advanced oxidation protein products) were chosen as oxidative damage approved markers. Our method presents several advantages over traditional methods as it is a direct, non-time-consuming, repeatable, and non-invasive technique that requires only simple pre-treatment of samples without additional reagents and the sample size needed for analysis is small. In principle, each modification of the protein in plasma can be expected to modify its fluorescence properties and hence its lifetime or intensity. The study involved 59 blood donors with no evidence of disease. The research was conducted at excitation wavelengths of 280 nm and 360 nm, and emission was measured at wavelengths of 350 nm and 440 nm, respectively. Our results, although preliminary, suggest that the application of fluorescence measurements can be considered as an effective marker of oxidative stress. Regression analyses showed that a notable growth in fluorescence intensity at 440 nm and a simultaneous decrease in fluorescence intensity and mean fluorescence lifetime at 350 nm are associated with higher levels of oxidative stress.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Frijhoff, J. et al. Clinical relevance of biomarkers of oxidative stress. Antioxid. Redox Signal 23(14), 1144–1170 (2015).
2. Lakowicz, J. R. Principles of Fluorescence Spectroscopy (Kluwer Academic/Plenum Publishers, 1999).
3. Lobo, V., Patil, A., Phatak, A. & Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 4(8), 118–126 (2010).
4. Henle, T. et al. Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol. Dial Transplant 14, 1968–1975 (1999).
5. Munch, G. et al. Determination of advanced glycation and products in serum by fluorescence spectroscopy and competitive ELISA. Eur. J. Clin. Chem. Clin. Biochem. 35, 669–677 (1997).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献